Successful Harmonization in EpiBioS4Rx Biomarker Study on Post-Traumatic Epilepsy Paves the Way Towards Powered Preclinical Multicenter Studies

Xavier Ekolle Ndode-Ekane,Idrish Ali,Cesar E Santana-Gomez,Pablo M Casillas-Espinosa,Pedro Andrade,Gregory Smith,Tomi Paananen,Eppu Manninen,Riikka Immonen,Noora Puhakka,Robert Ciszek,Elina Hämäläinen,Rhys D Brady,Juliana Silva,Emma Braine,Matthew R Hudson,Glenn Yamakawa,Nigel C Jones,Sandy R Shultz,David Wright,Neil Harris,Olli Gröhn,Richard J Staba,Terence J O'Brien,Asla Pitkänen,Cesar E. Santana-Gomez,Pablo M. Casillas-Espinosa,Rhys D. Brady,Matthew R. Hudson,Nigel C. Jones,Sandy R. Shultz,Richard J. Staba,Terence J. O’Brien

DOI: https://doi.org/10.1016/j.eplepsyres.2023.107263

IF: 2.991

2023-11-01

Epilepsy Research

Abstract:Objective Project 1 of the Preclinical Multicenter Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) consortium aims to identify preclinical biomarkers for antiepileptogenic therapies following traumatic brain injury (TBI). The international participating centers in Finland, Australia, and the United States have made a concerted effort to ensure protocol harmonization. Here, we evaluate the success of harmonization process by assessing the timing, coverage, and performance between the study sites. Method We collected data on animal housing conditions, lateral fluid-percussion injury model production, postoperative care, mortality, post-TBI physiological monitoring, timing of blood sampling and quality, MR imaging timing and protocols, and duration of video-electroencephalography (EEG) follow-up using common data elements. Learning effect in harmonization was assessed by comparing procedural accuracy between the early and late stages of the project. Results The animal housing conditions were comparable between the study sites but the postoperative care procedures varied. Impact pressure, duration of apnea, righting reflex, and acute mortality differed between the study sites (p 0.05). Plasma quality was poor in 4% of the samples in UEF, 1% in Monash and 14% in UCLA. More than 97% of the final cohort were MR imaged at all timepoints in all study sites. The timing of imaging did not differ on D2 and D9 (p > 0.05), but varied at D30, 5 months, and ex vivo timepoints (p 0.05). A decrease in acute mortality and increase in plasma quality across time reflected a learning effect in the TBI production and blood sampling protocols. Significance Our study is the first demonstration of the feasibility of protocol harmonization for performing powered preclinical multi-center trials for biomarker and therapy discovery of post-traumatic epilepsy.

clinical neurology